ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech
ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech Cambridge, MA (U.S.)…
ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech Cambridge, MA (U.S.)…
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Daix (France), Long Island City (New York, United States), September 28, 2021 – Inventiva (Euronext…
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — In a release issued on Tuesday, September 28th by Sorrento…
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY AUTHORIZATION TO COMMENCE A SECOND PHASE 2 COVID STUDY…
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) is…
This biological phenomenon, quorum sensing in macrophages, regulates the transition of cells from inflammatory to…
PALM BEACH GARDENS, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) — Accelus, a privately held medical…
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on…
AIM Has Reached Multiple Major Milestones Demonstrating Strong Progress in Developing its COVID-19 Portfolio OCALA,…
Duet releases video depicting mechanism of action for its proprietary CpG-STAT3 inhibitors to coincide with…
New York, NY, and Tel Aviv, ISRAEL, Sept. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
Three Biological-Based Herbicides Enter Late-Stage Development Phases; Potential $27 Billion Market DAVIS, Calif., Sept. 28,…
– Phase 2b study will investigate the efficacy of REVTx-99 on viral load and patient-reported…
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
Christine Brown, Ph.D., of City of Hope will present at the First Annual Conference on…
Trudhesa is the First and Only Therapeutic to Use POD® Technology to Deliver Dihydroergotamine Mesylate…
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Tryp Therapeutics Inc. (CSE:…
IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
Full year data reinforce strong safety profile consistent with previous trials of ONS-5010 and with…